Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • NCRI Groups
    • NCRI Networks
    • Proposal Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Early Career Researchers
    • Cancer Research Database
  • Areas of Interest
    • Cancer and Covid-19
    • Health Data and AI
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Pathology Group
    • Prevention and Early Diagnosis
    • Radiotherapy
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

Radiotherapy

Filter Posts By:

  • Areas of Interest
    • Cancer Research Funding
    • Clinical Research Delivery
    • COVID-19
    • Health Data and AI
    • Imaging
    • Immunotherapy & Immunology
    • Living With & Beyond Cancer
    • Pathology
    • Patient & Public Involvement
    • Prevention & Early Diagnosis
    • Radiotherapy
    • Training & Retention
  • Cancers
    • Bladder & Renal
    • Brain
    • Breast
    • Children
    • Colorectal
    • Gynaecological
    • Haematological
    • Head & Neck
    • Lung
    • Lymphoma
    • Prostate
    • Sarcoma
    • Skin
    • TYA
    • Upper Gastrointestinal
  • Content
    • Blog
    • Case Study
    • Interviews
    • News
    • Press Releases

Reset Filters

'

Celebrating ten years of NCRI’s Clinical and Translational Radiotherapy Research Group

'
20 May 2019

NCRI’s Radiotherapy Research Group (CTRad) is one of NCRI’s flagship initiatives and this June we are celebrating its ten year…

Read More

'

Prof Mererid Evans appointed NCRI CTRad Deputy Chair

'
29 April 2019

We are pleased to announce that, following an open competitive recruitment process, Prof Mererid Evans has been appointed as NCRI…

Read More

'

Developing the UK research strategy for Proton Beam Therapy

'
20 February 2019

Thanks to a £250m investment from the UK government, the first of two NHS Proton Beam Therapy (PBT) centres has…

Read More

'

Patients with low risk thyroid cancer can receive lower doses of radiation treatment

'
05 November 2018

Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of…

Read More

'

UK contribution to global radiotherapy research shines out in recent review

'
21 September 2018

To mark the 150th birthday of Marie Curie, the ‘Godmother of Radiotherapy’, NCRI’s Radiotherapy Research Group (CTRad) reviewed key practice…

Read More

'

Developing a consensus for the future of radiotherapy-drug research

'
23 April 2018

Despite increasing numbers of radiotherapy trials and rising recruitment, a continuing challenge has been increasing the number of trials evaluating…

Read More

'

Developing better cancer trials for non-small cell lung cancers

'
23 April 2018

A consortium established by NCRI CTRad and the NCRI Lung Group to address the lack of radiotherapy and drug combination…

Read More

'

CTRad: moving boldly into the next phase 2018-2021

'
18 April 2018

Since its inception in 2009, NCRI’s flagship radiotherapy initiative, the Clinical and Translational Radiotherapy Research Working Group (CTRad), has achieved…

Read More

'

Identifying more harm than good: The PRIMETIME breast cancer study

'
09 January 2018

PRIMETIME is a research study in early breast cancer investigating whether it’s possible to identify a group of women with…

Read More

'

Big data analysis predicts risk of radiotherapy side effects

'
07 November 2017

Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer, according to…

Read More

'

CTRad: Progress to date and ambitions beyond 2018

'
19 September 2017

Since its inception in 2009, NCRI’s flagship initiative, the Clinical and Translational Radiotherapy Research Working Group (CTRad), has achieved considerable…

Read More

'

CTRad’s new strategic vision 2018-2021

'
26 July 2017

In light of progress made in the past three years, CTRad’s Executive Group put together a mission statement to guide…

Read More

Posts navigation

  • «
  • 1
  • 2
  • 3
  • 4
  • »

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter